27,146 Shares in Avantor, Inc. (NYSE:AVTR) Bought by Aristeia Capital L.L.C.

Aristeia Capital L.L.C. purchased a new stake in shares of Avantor, Inc. (NYSE:AVTR) in the second quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 27,146 shares of the company’s stock, valued at approximately $575,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of AVTR. Versant Capital Management Inc lifted its holdings in shares of Avantor by 2,003.6% in the second quarter. Versant Capital Management Inc now owns 1,157 shares of the company’s stock valued at $25,000 after purchasing an additional 1,102 shares in the last quarter. Blue Trust Inc. boosted its holdings in Avantor by 1,830.3% during the 2nd quarter. Blue Trust Inc. now owns 1,467 shares of the company’s stock worth $31,000 after acquiring an additional 1,391 shares during the last quarter. TFO Wealth Partners LLC grew its stake in shares of Avantor by 203,100.0% in the 4th quarter. TFO Wealth Partners LLC now owns 2,032 shares of the company’s stock worth $46,000 after acquiring an additional 2,031 shares in the last quarter. MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH purchased a new stake in shares of Avantor in the first quarter valued at about $93,000. Finally, ORG Partners LLC lifted its position in shares of Avantor by 5,773.0% during the second quarter. ORG Partners LLC now owns 5,873 shares of the company’s stock valued at $122,000 after purchasing an additional 5,773 shares in the last quarter. Institutional investors own 95.08% of the company’s stock.

Insider Buying and Selling

In other Avantor news, CAO Steven W. Eck sold 3,525 shares of the stock in a transaction that occurred on Thursday, September 5th. The shares were sold at an average price of $25.06, for a total value of $88,336.50. Following the sale, the chief accounting officer now directly owns 29,544 shares in the company, valued at approximately $740,372.64. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 1.50% of the stock is currently owned by insiders.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on AVTR. Barclays upped their price objective on shares of Avantor from $25.00 to $28.00 and gave the stock an “overweight” rating in a research report on Monday, July 29th. Evercore ISI decreased their price target on Avantor from $28.00 to $27.00 and set an “outperform” rating for the company in a research report on Tuesday, July 2nd. Wells Fargo & Company assumed coverage on Avantor in a research report on Tuesday, August 27th. They issued an “overweight” rating and a $30.00 price objective on the stock. Citigroup cut Avantor from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $30.00 to $23.00 in a research note on Wednesday, July 10th. Finally, Morgan Stanley increased their price target on shares of Avantor from $28.00 to $29.00 and gave the company an “overweight” rating in a research report on Monday, July 29th. Four analysts have rated the stock with a hold rating and twelve have given a buy rating to the company’s stock. According to MarketBeat.com, Avantor currently has a consensus rating of “Moderate Buy” and an average target price of $27.40.

Avantor Trading Down 1.5 %

Shares of AVTR stock opened at $26.58 on Tuesday. The stock has a market capitalization of $18.05 billion, a price-to-earnings ratio of 68.15, a PEG ratio of 2.75 and a beta of 1.32. The company’s fifty day simple moving average is $25.16 and its two-hundred day simple moving average is $24.36. Avantor, Inc. has a 1 year low of $16.63 and a 1 year high of $28.00. The company has a debt-to-equity ratio of 0.89, a current ratio of 1.59 and a quick ratio of 1.05.

Avantor (NYSE:AVTR) last released its quarterly earnings data on Friday, July 26th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.23 by $0.02. Avantor had a return on equity of 12.40% and a net margin of 5.28%. The company had revenue of $1.70 billion for the quarter, compared to analyst estimates of $1.70 billion. As a group, analysts anticipate that Avantor, Inc. will post 1.01 earnings per share for the current year.

Avantor Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.